Literature DB >> 23045165

Impact of calcium and vitamin D insufficiencies on serum parathyroid hormone and bone mineral density: analysis of the fourth and fifth Korea National Health and Nutrition Examination Survey (KNHANES IV-3, 2009 and KNHANES V-1, 2010).

Nam-Seok Joo1, Bess Dawson-Hughes, Young-Sang Kim, Kyungwon Oh, Kyung-Jin Yeum.   

Abstract

The relative contributions of calcium and vitamin D to calcium metabolism and bone mineral density (BMD) have been examined previously, but not in a population with very low calcium intake. To determine the relative importance of dietary calcium intake and serum 25-hydroxyvitamin D [25(OH)D] concentration to calcium metabolism and bone mass in a population with low calcium intake, a total of 4662 adults (2567 men and 2095 women) ≥50 years of age from the 2009-2010 Korea National Health and Nutrition Examination Survey (KNHANES) were divided into groups according to dietary calcium intakes (quintiles means: 154, 278, 400, 557, and 951 mg/d) and serum 25(OH)D concentrations (<50, 50-75, and >75 nmol/L). Serum intact parathyroid hormone (PTH) and femoral neck and lumbar spine BMD were evaluated according to dietary calcium intake and serum 25(OH)D. Mean calcium intake was 485 mg/d; mean serum 25(OH)D concentration was 48.1 nmol/L; PTH was 68.4 pg/mL; femoral neck BMD was 0.692 g/cm(2) ; and lumbar spine BMD was 0.881 g/cm(2) . Lower dietary calcium intakes were significantly associated with higher serum PTH concentrations and lower femoral neck BMD, not only at lower (<50 nmol/L) but also at higher (>75 nmol/L) serum 25(OH)D concentrations. Serum PTH was highest and femoral neck BMD was lowest in the group, with a serum 25(OH)D less than 50 nmol/L. In this low-intake population, calcium intake is a significant determinant of serum PTH and BMD at higher as well as lower 25(OH)D levels. This finding indicates that low calcium intake cannot be compensated for with higher 25(OH)D levels alone. As expected, serum 25(OH)D levels were inversely associated with serum PTH and BMD. A calcium intake of at least 668 mg/d and a serum 25(OH)D level of at least 50 nmol/L may be needed to maintain bone mass in this calcium deficient population.
Copyright © 2013 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23045165     DOI: 10.1002/jbmr.1790

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  35 in total

1.  Favorable effect of dietary vitamin C on bone mineral density in postmenopausal women (KNHANES IV, 2009): discrepancies regarding skeletal sites, age, and vitamin D status.

Authors:  Y A Kim; K M Kim; S Lim; S H Choi; J H Moon; J H Kim; S W Kim; H C Jang; C S Shin
Journal:  Osteoporos Int       Date:  2015-04-24       Impact factor: 4.507

2.  Bone mineral density change during adjuvant chemotherapy in pediatric osteosarcoma.

Authors:  Ju Hyun Ahn; Wan Hyeong Cho; Jun Ah Lee; Dong Ho Kim; Ju-Hee Seo; Jung Sub Lim
Journal:  Ann Pediatr Endocrinol Metab       Date:  2015-09-30

3.  Low calcium and vitamin D intake in Korean women over 50 years of age.

Authors:  Young-Kyun Lee; Jae-Suk Chang; Yong-Ki Min; Dong-Won Byun; Yongsoon Park; Yong-Chan Ha
Journal:  J Bone Miner Metab       Date:  2016-09-28       Impact factor: 2.626

4.  Association between bone mineral density, muscle strength, and vitamin D status in patients with myasthenia gravis: a cross-sectional study.

Authors:  Y Guan; F Lv; Y Meng; D Ma; X Xu; Y Song; O Wang; Y Jiang; W Xia; X Xing; J Zhang; M Li
Journal:  Osteoporos Int       Date:  2017-04-24       Impact factor: 4.507

5.  Development and validation of osteoporosis risk-assessment model for Korean postmenopausal women.

Authors:  Sun Min Oh; Byung-Ho Nam; Yumie Rhee; Seong-Hwan Moon; Deog Young Kim; Dae Ryong Kang; Hyeon Chang Kim
Journal:  J Bone Miner Metab       Date:  2013-02-19       Impact factor: 2.626

6.  Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral density.

Authors:  M Li; F Lv; Z Zhang; W Deng; Y Li; Z Deng; Y Jiang; O Wang; X Xing; L Xu; W Xia
Journal:  Osteoporos Int       Date:  2016-01-05       Impact factor: 4.507

7.  Calcium revisited: part I.

Authors:  Peter Burckhardt
Journal:  Bonekey Rep       Date:  2013-10-16

8.  The effect of calcium and vitamin D supplementation on osteoporotic rabbit bones studied by vibrational spectroscopy.

Authors:  Athina Lani; Nikolaos Kourkoumelis; Gerasimos Baliouskas; Margaret Tzaphlidou
Journal:  J Biol Phys       Date:  2014-07-09       Impact factor: 1.365

9.  The effects of switching daily teriparatide to oral bisphosphonates or denosumab in patients with primary osteoporosis.

Authors:  Kosuke Ebina; Jun Hashimoto; Masafumi Kashii; Makoto Hirao; Shoichi Kaneshiro; Takaaki Noguchi; Yasunori Tsukamoto; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2016-01-13       Impact factor: 2.626

10.  Assessment of the effects of switching oral bisphosphonates to denosumab or daily teriparatide in patients with rheumatoid arthritis.

Authors:  Kosuke Ebina; Makoto Hirao; Jun Hashimoto; Keisuke Hagihara; Masafumi Kashii; Kazuma Kitaguchi; Hozo Matsuoka; Toru Iwahashi; Ryota Chijimatsu; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2017-08-01       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.